biomedicina slovenica

re="Clinical : 477-576

  1. Zupan Marko
    Epilepsy and alcohol
    2002 ►
  2. Lorber Bogdan
    Juvenile myoclonic epilepsy
    2002 ►
  3. Butinar Dušan
    Photosensitive epilepsies
    2002 ►
  4. Kržan Matevž J
    Videotelemetry
    2002 ►
  5. Žgur Tomaž
    Long-term video electroencephalography in epilepsy
    2002 ►
  6. Trinka Eugen
    Temporal lobe epilepsies
    2002 ►
  7. Trinka Eugen
    Seizure unit - preoperative video electroencephalographic diagnostics
    2002 ►
  8. Chauvel Patric
    High-resolution electroencephalography in clinical neurophysiology: applications to epilepsy and evoked potentials
    2002 ►
  9. Stegnar Mojca
    Atherothrombosis: pathogenesis of cardiovascular disease
    2002 ►
  10. Borštnar S; Vrhovec I; Svetič B; Čufer T
    Prognostic value of the urokinase-type plasminogen activator, and its inhibitors and receptor in breast cancer patients
    2002 ►
  11. Kržan M; Deletis V; Isgum V
    Intraoperative neurophysiological mapping of dorsal columns. A new tool in the prevention of surgically induced sensory deficit?
    1997 ►
  12. Trontelj Jože V; Stalberg Erik
    Single-fiber and macro electromyography
    2002 ►
  13. Levičar Nataša; Daley Emma; Dewey Ricardo A; Bates Timothy E; Pilkington Geoffrey J; Lah Tamara T
    Cathepsin L in apoptosis and human glinoma invasion
    2002 ►
  14. Hawlina M; Popović P; Jarc-Vidmar M; Kapetanovič M; Korpič A; Brecelj J
    Multifocal ERG and PERG in maculopathies in relation to RPE autofluorescence imaging
    2002 ►
  15. Brecelj J; Stirn-Kranjc B
    Visual electrophysiological recording in infants
    2002 ►
  16. Pfeifer Vladimir
    Phaco chop versus phaco crack
    1999 ►
  17. Jenko S; Miharija-Gala T; Tegelj I; Urh S
    Use of reserved antibiotics in surgical departments of the University medical centre Ljubljana
    2002 ►
  18. Penovski-Plevčak D; Miharija-Gala T; Franko R; Lubej M
    The organization of pharmaceutical care for pacients with short bowel syndrome
    2002 ►
  19. Penovski-Plevčak D; Miharija-Gala T; Lubej M; Fortuna M
    Influence of the clinical pharmacist on the quality assorance of cytotoxic therapy in the University medical centre Ljubljana
    2002 ►
  20. Ferlan A; Kočevar-Nared J
    Drug market surveillance in Slovenia: 3-years period experience
    2002 ►
  21. Čičigoj L; Mrhar A
    A case documented project of pharmaceutical care for osteoporosis in a community pharmacy
    2002 ►
  22. Milovanovič M; Frankič D
    Pharmaceutical care for patients with hypertension in Slovenian pharmacies
    2002 ►
  23. Kos M; Primožič S; Umek A; Kralj M; Mlinarič A
    Attitudes of lay public towards phytotherapeutics and the role of community oharmacist in phytotherapy
    2002 ►
  24. Jurečič V; Gabrovšek L
    Polypharmacy - the community pharmacist contribution to diabetes patients
    2002 ►
  25. Čater N; Pavlovič L
    Pharmaceutical care is an important project in the prevention of the diseases
    2002 ►
  26. Štotl J; Čufer T; Kozjek F; Sonc M
    Comparison of quality of lif of breast cancer patients, treated with two diferent chemotherapeutic schemes
    2002 ►
  27. Kobal Nataša; Kariž Stojan
    Use of antimicrobial drugs in General hospital Izola from 1996 to 2000
    2002 ►
  28. Mitrovič S; Miharija-Gala T; Tegelj I; Urh S; Baler M
    Preparation and testing of acetylcysteine solurion for individual treatment
    2002 ►
  29. Baler M; Tršan M; Miharija-Gala T
    Individualized therapy and potentiometric titration of active ingredients
    2002 ►
  30. Vodopivec V; Miharija-Gala T; Tršan M; Baler M
    Cardioplegia solution: preparation and stability
    2002 ►
  31. Šantel Z; Mušič E; Primožič S
    Pharmacokinetic interactions of theophylline with other drugs
    2002 ►
  32. Rupnik-Ravnihar I; Kozjek F; Antolič G
    Pharmacokinetic/pharmacodynamic modelling of tramadol
    2002 ►
  33. Schweiger E; Kozjek F; Antolič G
    Prediction of pharmacokinetic parameters of nitrendipine by artificial neural networks
    2002 ►
  34. Sikošek-škulj T; Stamos V; Bačar C; Kozjek F
    Kinetics of lithium carbonate and thyroid stimulating hormone interaction
    2002 ►
  35. Skerbinjak-Kavalar M; Brunčko A; Primožič S; Kos M; Lampe-Ivanovska D; Strbad E
    Follow-up of safety and effectiveness of fluticasone propionate in children and adolescents with asthma
    2002 ►
  36. Miharija-Gala T; Obersnel D; Lubej M
    Influence of the clinical pharmacist on rational preparation and consumption of drugs for pain management
    2002 ►
  37. Peklar J; Tratar F; Mrhar A
    Cost effectiveness analysis of implementation of drug formulary for antimicrobials in General hospital Celje
    2002 ►
  38. Silič A; Janež A; Kozjek F; Tomažič J
    Metabolic abnormalities associated with highly active antiretroviral therapy (HAART) in HIV infected patients in Slovenia
    2002 ►
  39. Borovničar A; Keber I
    Improvement of functional parameters of arterial wall and microcirculation in subjects with hypercholesterolemia after vitamin E supplementation
    2002 ►
  40. Košnik Mitja
    New drugs and delivery systems in the treatment of asthma
    2002 ►
  41. Eržen R; Mušič E; Tomič V; Remškar Z
    Analysis of hospital treated community-acquired pneumonia
    2002 ►
  42. Štabuc-Šilih M; Štabuc B
    Keratoconus and ehlers-danlos syndrome
    2002 ►
  43. Hawlina M; Hvala A; Perkovič T
    Ultrastructure of human anterior lens capsule in intumescent white cataracts
    2002 ►
  44. Trontelj Jože V; Sanders Donald B; Stalberg Erik V
    Electrophysiological methods for assessing neuromuscular transmission
    2002 ►
  45. Čokolič M; Hren R
    Alendronate treatment of male patients with idiopathic osteoporosis
    2002 ►
  46. Hren R; Breznik M; Čokolič M
    Quality of life issues in postmenopausal osteoporosis: the patient's perspective
    2002 ►
  47. Meško-Brguljan P; Krašovec M; Šuškovič S; Kos J; Cimerman N
    Balance in asthma between serum cysteine proteinases and their inhibitors
    2002 ►
  48. Božič B; Čučnik S; Ambrožič A; Lestan B; Kos-Golja M; Rozman B; Kveder T
    Antibodies against cyclic citrulinated peptide in patients with rheumatoid arthritis
    2002 ►
  49. Svetic B; Vrhovec I; Kramberger M; Borštnar S; Čufer T
    The influence of different buffers on tumor tissue preparation for biochemical determination of cathepsins D and L
    2002 ►
  50. Avberšek-Lužnik I; Benedik M; Malešič I; Marc J
    Serum osteoprotegerin level and bone turnover in dialysis patients
    2002 ►
  51. Prezelj M; Kersnik M; Schara M
    Effect of superoxide generated by xanthine oxidase/hypoxanthine system on red blood cell
    2002 ►
  52. Pajič T; Zagradišnik B; Urlep-Šalinovič V; Kokalj-Vokač N; Kralj J
    FV Leiden, Protrombin G20210A and methylenetetrahydrofolate reductase C677T mutation detection on the lightcycler
    2002 ►
  53. Meško-Brguljan Pika; Bratož Saša
    Quality and accreditation of clinical chemistry laboratories: state-of-the-art in Slovenia
    2002 ►
  54. Šeruga T
    Percutaneous vertebroplasty in patients with spine compression fractures due to osteoporosis
    2002 ►
  55. Pečovnik-Balon Breda; Hojs Radovan; Bren Andrej
    Bone histomorphometry is still the golden standard for diagnosing renal osteodystrophy
    2001 ►
  56. Sonc M; Beravs A; Kozjek F; Primožič S
    Pharmacoeconomic analysis of lung cancer treatment with gemcitabine
    2001 ►
  57. Perharič L; Maver S; Jamšek M
    Cerebral infarction due to phosphine gas poisoning
    2000 ►
  58. Šarc L; Jamšek M
    DMPS in the treatment of chronic lead poisoning
    2000 ►
  59. Grošelj C; Kukar M
    Improving the accuracy of myocardial perfusion scintigraphy results by machine learning method
    2002 ►
  60. Fidler Valentin; Prepadnik Milan
    Upgrading of analogue gamma cameras with PC based computer system
    2002 ►
  61. Pirnat E; Fidler V; Zaletel K; Gaberšček S; Hojker S
    The early changes of thyroid hormone concentrations after 131I therapy for graves' hyperthyroidism - the role of pretreatment with methimazole
    2002 ►
  62. Zaletel K; Gaberšček S; Pirnat E; Hojker S
    Incidence of hyperthyroidism in Slovenia since improved iodine supply
    2002 ►
  63. Koselj Miha; Koselj Mira; Kandus Aljoša; Bren Andrej
    Infectious complications of immunosuppressive treatment for Anca-related vasculitis
    2002 ►
  64. Bren Andrej; Kandus Aljoša; Kovač Damjan; Koselj Mira; Buturović Jadranka; Lindič Jelka; Vizjak Alenka; Ferluga Dušan
    Outcome and prognosis of cyclosporine (CS) related hemolytic-uremic syndrome (HUS) in kidney graft recipients - clinical and histopathologic study of 13 cases
    2002 ►
  65. Marc Janja
    Bone remodelling in diabetes mellitus
    2001 ►
  66. Bren Andrej; Koselj Mira; Kandus Aljoša; Kovač Damjan; Lindič Jelka; Črnej Alja; Grego Katarina
    Severe fungal infections in kidney graft recipients
    2002 ►
  67. Ponikvar Rafael R; Kandus Aljoša S; Bren Andrej F; Buturovič-Ponikvar Jadranka
    Side effects of protein a immunoadsorption and plasma exchange therapy in renal allograft recipients
    2002 ►
  68. Stegnar Mojca
    Disturbances of hemostasis in diabetes mellitus contributing to the development of atherosclerosis
    2001 ►
  69. Buturovič-Ponikvar Jadranka; Novljan Gregor; Ponikvar Rafael
    Cosmetic side effects of immunosuppressive therapy in children and adolescents with renal graft
    2002 ►
  70. Černe Darko
    Early detection of chronic complications: diabetic nephropathy
    2001 ►
  71. Koselj Mira; Kandus Aljoša; Bren Andrej
    Posttransplant diabetes mellitus - a serious complication of immunosuppression in renal allograft recipients
    2002 ►
  72. Božič Borut
    Diabetes and autoimmunity
    2001 ►
  73. Černelč Peter
    Maintenance treatment of primary plasma cell leukemia with interferon alpha
    2002 ►
  74. Preložnik-Zupan Irena; Zver Samo; Pretnar Jože
    Immunosuppresive treatment of severe acute graft versus host disease after allogeneic haematopoetic stem cell transplantation
    2002 ►
  75. Kandus Aljoša
    Prevention of acute rejection with basiliximab and triple immunosuppression after renal transplantation
    2002 ►
  76. Modic Mojca; Černelč Peter; Zver Samo
    Should be splenectomy really the last option of immunosupressive therapy in patients with chronic or relapsing idiopathic thrombotic thrombocytopenic purpura
    2002 ►
  77. Lokar L; Urlep-Šalinović V; Zagradišnik B; Kokalj-Vokač N
    Correlation beetwen ProC Global assay and coagulation inhibitor assays
    2001 ►
  78. Kastelic Andrej; Kostnapfel-Rihtar Tatja
    Integrating methadone treatment in the Slovenian public health system
    1999 ►
  79. Stalberg Erik; Falck Bjoern
    The role of electromyography in neurology
    2001 ►
  80. Samama Meyer Michel; Desnoyers Pierre; Gerotziafas Grigoris T
    Low molecular weight heparins: a comparative review of pharmacodynamic, clinical pharmacology
    2001 ►
  81. Samama MM; Kher A
    Anticoagulation: the old and new
    2001 ►
  82. Scholz T; Krause S; Finkelberg L; Loesche W
    Detection of small platelet aggregates and their inhibition by glycoprotein IIb/IIIa antagonists in a laser aggregometer
    2001 ►
  83. Niessner A; Kaun C; Christiansen G; Pedersen AS; Simon S; Zorn G; Georgopoulos A; Graninger W; Huber K; Wojta J
    Outer membrane protein 11 (OMP 11) and OMP 15 of Chlamydia pneumoniae induce the chemokine interleukin-8 (IL-8) and the pro-inflammatory cytokine IL-6 in human endothelial cells in vitro
    2001 ►
  84. Weiss T; Macfelda K; Kaun C; Zorn G; Kapeller B; Springer C; Bialy J; Losert UM; Breuss JM; Binder BR
    Inflammatory cytokines and growth factors regulate plasminogen activator inhibitor-1 (PAI-1) in human adult cardiac myocytes (HACM)
    2001 ►
  85. Miles LA; Green M; Gong A; Jardi M; Felez J
    Monoclonal antibodies detect receptor-induced binding sites (RIBS) in plasminogen induced by its interaction with cells
    2001 ►
  86. Barrowcliffe TW; Jardi M; Cancelas JA; Rabaneda M; Fabregas P; Felez J
    Procoagulant activity of T lymphoblastoid cells due to exposure of negatively charged phospholipid
    2001 ►
  87. Barrowcliffe TW; Rabaneda M; Gray E; Felez J
    Procoagulant activity of activated endothelial cells - the importance of negatively charged phospholipids
    2001 ►
  88. Speidl WS; Graf S; Nikfardjam M; Niessner A; Zorn G; Wojta J; Huber K
    High sensitivity C-reactive protein predicts risk for further coronary events in stable patients with premature coronary artery disease
    2001 ►
  89. Hiltunen L; Paunio M; Kaaja R; Vahtera E; Krusius T; Rasi V
    A prospective nested case control study of thromboembolic complications of pregnancy
    2001 ►
  90. Kuismanen K; Salonvaara M; Mononen T; Riikonen P
    Treatment of a newborn with neonatal purpura fulminans in a family with hereditary type II protein C deficiency
    2001 ►
  91. Niessner A; Hornykewycz S; Joerg M; Zorn G; Graf S; Binder BR; Huber K
    Increased risk of restenosis after successful percutaneous transluminal coronary angioplasty in patients with permanently elevated anticardiolipin antibodies
    2001 ►
  92. Michiels JJ; Kasbergen HAA; Trienekens PH
    Evidence for safe exclusion of deep vein thrombosis (DVT- by a rapid ELISA D-dimer test in 434 consecutive outpatients with suspected DVT
    2001 ►
  93. Michiels JJ; Posthuma W; Ponjee GAE; Stef E; Quint WG; van Doorn LJ
    DNA typing for thrombophilia-related factor V leiden and prothrombing G20210A mutations by multiplex PCR and reverse hybridisation LiPA in 473 thrombosis patients
    2001 ►
  94. Furlan M
    New strategies in diagnosis and treatment of thrombocitic thrombocytopenic purpura
    2001 ►
  95. Vermylen J
    Heparin-induced thrombocytopenia
    2001 ►
  96. Prandoni P
    The optimal treatment of venous thrombosis
    2001 ►
  97. Vermylen J
    Platelet glycoprotein receptor antagonists
    2001 ►
  98. Felez J
    Cell surface associated fibrinolysis
    2001 ►
  99. Blinc A
    Transport of fibrinolytic agents as a rate-limiting step in fibrinolysis and thrombolysis
    2001 ►
  100. Palareti G
    Laboratory and therapeutic quality control of anticoagulant treatment: an update
    2001 ►

   1 77 177 277 377 477 577 677 777 877  

Nova poizvedba      Pripombe      Na vrh strani                        Inštitut za biostatistiko in medicinsko informatiko